1. Home
  2. AVXL vs ASTE Comparison

AVXL vs ASTE Comparison

Compare AVXL & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • ASTE
  • Stock Information
  • Founded
  • AVXL 2004
  • ASTE 1972
  • Country
  • AVXL United States
  • ASTE United States
  • Employees
  • AVXL N/A
  • ASTE N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • ASTE Construction/Ag Equipment/Trucks
  • Sector
  • AVXL Health Care
  • ASTE Industrials
  • Exchange
  • AVXL Nasdaq
  • ASTE Nasdaq
  • Market Cap
  • AVXL 794.0M
  • ASTE 777.8M
  • IPO Year
  • AVXL N/A
  • ASTE N/A
  • Fundamental
  • Price
  • AVXL $12.74
  • ASTE $39.86
  • Analyst Decision
  • AVXL Strong Buy
  • ASTE Hold
  • Analyst Count
  • AVXL 2
  • ASTE 1
  • Target Price
  • AVXL $44.00
  • ASTE $41.00
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • ASTE 177.8K
  • Earning Date
  • AVXL 08-05-2025
  • ASTE 08-06-2025
  • Dividend Yield
  • AVXL N/A
  • ASTE 1.31%
  • EPS Growth
  • AVXL N/A
  • ASTE N/A
  • EPS
  • AVXL N/A
  • ASTE 0.66
  • Revenue
  • AVXL N/A
  • ASTE $1,325,300,000.00
  • Revenue This Year
  • AVXL N/A
  • ASTE $5.43
  • Revenue Next Year
  • AVXL N/A
  • ASTE $4.22
  • P/E Ratio
  • AVXL N/A
  • ASTE $59.73
  • Revenue Growth
  • AVXL N/A
  • ASTE 1.99
  • 52 Week Low
  • AVXL $4.93
  • ASTE $29.04
  • 52 Week High
  • AVXL $14.44
  • ASTE $43.35
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 69.01
  • ASTE 48.80
  • Support Level
  • AVXL $10.98
  • ASTE $37.82
  • Resistance Level
  • AVXL $11.33
  • ASTE $39.77
  • Average True Range (ATR)
  • AVXL 0.75
  • ASTE 1.26
  • MACD
  • AVXL 0.15
  • ASTE -0.15
  • Stochastic Oscillator
  • AVXL 69.36
  • ASTE 37.47

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: